Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Katalin Scherer
Professor, Neurology - (Clinical Scholar Track)
Neurology
Full Page
Overview
Research
More
Collaboration
(11)
William Montfort
Mutual work: 4 Publications
Collaboration Details
Cori Daines
Mutual work: 5 Publications
Collaboration Details
Jennifer Andrews
Mutual work: 2 Publications
Collaboration Details
Michael Hammer
Mutual work: 1 Proposal﹒3 Publications
Collaboration Details
Michael Seckeler
Mutual work: 4 Publications
Collaboration Details
Page 1 of 3
Previous page
Next page
Grants
(4)
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo- Controlled Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to...
2019
·
$92.8K
·
External
Principal Investigator (PI)
clinical trial,
pharmacokinetics,
pharmacodynamics,
safety,
efficacy
An Open-label Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients with Generalized Myasthenia Gravis
2019
·
$51K
·
External
Principal Investigator (PI)
drug safety,
treatment efficacy,
myasthenia gravis,
clinical trial,
patient tolerability
Identification of Diagnostic and Prognostic Biomarkers From ALS Adipose and Skin
2009
·
$13.6K
·
External
Principal Investigator (PI)
biomarkers,
als,
adipose,
skin,
diagnostic
Myozyme Temporary Access Program (MTAP)
2007
·
$144K
·
External
Principal Investigator (PI)
rare diseases,
clinical trials,
drug access,
enzyme replacement therapy,
patient support
Publications
(13)
Recent
An immune tolerance approach using transient low-dose methotrexate in the ERT-naïve setting of patients treated with a therapeutic protein: experience in infantile-onset Pompe disease.
2019
immune tolerance,
methotrexate,
ert-naïve,
therapeutic protein,
pompe disease
variants in cause sporadic early-onset progressive sensorimotor neuropathy
2019
genetics,
neuroscience,
neuropathy,
variation,
progressive
Safe Transition to Pembrolizumab following Ipilimumab-Induced Guillain-Barré Syndrome: A Case Report and Review of the Literature
2019
immunotherapy,
adverse events,
case report,
neurological complications,
treatment transition
An immune tolerance approach using transient low-dose methotrexate in the ERT-naïve setting of patients treated with a therapeutic protein: experience in infantile-onset Pompe disease
2018
immunotherapy,
enzyme replacement therapy,
pompe disease,
immune tolerance,
methotrexate
A sporadic case of severe peripheral neuropathy expands the phenotypic range of TUBB2A mutations.
2017
neuropathy,
genetic mutations,
tubb2a,
phenotypic range,
peripheral
Regional and Racial Variation in Hospitalization Costs in Patients with Duchenne Muscular Dystrophy
2016
healthcare,
medical cost,
genetic disease,
patient outcomes,
health disparities
Diaphragm pacing in amyotrophic lateral sclerosis: a literature review
2012
Measuring disease severity in Duchenne and Becker Muscular Dystrophy
2010
Radial nerve palsy in Guillain-Barré syndrome.
2009
Hanging leg syndrome: combined bilateral femoral and sciatic neuropathies.
2006